Dr.Zadorin Eugene, PhD, MBA
International BioPharmaceutical Association,
Member of European Forum of GCP , Gerson
Lehrman healthcare Council, First Clinical Research LLC Speakers
Bureau, former head of consulting Group of the Department of Clinical Research of MOH
Effective clinical trial auditing reduces the risk of violations, which could result in regulatory enforcement and product delays. This training course provides a step-by-step foundation for auditing to comply with Good Clinical Practices (GCPs). Examples of common site deficiencies and tips on how to detect hidden problems are explored along with implementation of an efficient corrective action plan. Techniques are discussed for evaluating and updating SOPs. You will learn how to ensure HIPAA compliance and how to meet informed consent requirements. Finally, methods to detect fraud and misconduct will be highlighted. Throughout the course, interactive exercises and case study analysis will add to the overall learning experience. In two days, you will learn everything you need to know to protect your company and your patients from serious and harmful risks.
GCP certification is the formal recognition of clinical research professionals who have met professional eligibility requirements and demonstrated job-related knowledge and skills. The NBScience's certification is granted in recognition of documented and verified work experience and successful performance on a multiple-choice exam.
The success of the NBScience international is built on forging profitable business relationships between the Pharmaceutical and Biotechnology industries and their partners in clinical research.
With our 5 years of experience in increasing our partners' return on investment we've developed winning strategies guaranteed to build and sustain successful partnerships in clinical trials outsourcing.
pharmaceutical companies
CRO
Investigators
GCP,cGMP auditors
NBScience already has many partnerships with societies, universities, statutory organisations and NGOs locally, nationally and internationally. We aim to strengthen these relationships and develop new collaborations in the future.